Adaptive Biotechnologies ADPT Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Adaptive Biotechnologies's change in AR?
- Adaptive Biotechnologies (ADPT) reported change in AR of -$2.05M in Q1 2026.
- How has Adaptive Biotechnologies's change in AR changed year-over-year?
- Adaptive Biotechnologies's change in AR decreased by 210.0% year-over-year, from $1.86M to -$2.05M.
- What is the long-term trend for Adaptive Biotechnologies's change in AR?
- Over 2 years (2022 to 2025), Adaptive Biotechnologies's change in AR has grown at a -38.2% compound annual growth rate (CAGR), from $22.65M to $8.65M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.